A Profibrotic Function of IL-12p40 in Experimental Pulmonary Fibrosis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The p40 subunit of IL-12 (IL-12p40), but not the heterodimeric form IL-12p70, is secreted during the development of silica-induced lung fibrosis in C57BL/6 mice. To delineate the contribution of IL-12p40 to the lung inflammatory and fibrotic processes, we compared the pulmonary responses with silica particles of IL-12p35-deficient mice (IL-12p35−/−, able to produce IL-12p40) and IL-12p40-deficient mice (IL-12p40−/−). IL-12p35−/− and IL-12p40−/− animals developed strikingly contrasting responses to silica in comparison with wild-type C57BL/6 mice. Although the IL-12p40−/− mice exhibited limited inflammatory and fibrotic reactions, the IL-12p35−/− mice presented a robust and well-developed pulmonary inflammation and fibrosis. Furthermore, the silica-induced increase in lung IL-12p40 content was significantly higher in IL-12p35−/− mice than in wild-type controls, and was associated with extensive lung fibrosis and pulmonary macrophage infiltration. The contrasting responses observed between these two IL-12 subunit-deficient murine strains were not accompanied by a strict type 1 or type 2 polarization as estimated by the measurements of lung IFN-γ/IgG2a and IL-4/IgG1 content. In vitro proliferation, type I collagen expression, as well as myofibroblast differentiation of purified pulmonary fibroblasts were not affected by treatment with exogenous rIL-12p40. In vivo, supplementation with rIL-12p40 restored the impaired pulmonary fibrotic response and macrophage accumulation in silica-treated IL-12p40−/− mice, and also promoted fibrosis and macrophage influx in wild-type mice. Together, our data suggest that IL-12p40 plays an important role in silica-induced pulmonary inflammation and fibrosis, possibly by exacerbating macrophage recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
IL-12 attenuates bleomycin-induced pulmonary fibrosis
Keane, M. P., Belperio, J. A., Burdick, M. D., & Strieter, R. M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l92 · Cited by 146
Nakamura, H., Fujishima, S., Waki, Y., Urano, T., Sayama, K., Sakamaki, F., Terashima, T., Soejima, K., Tasaka, S., & Ishizaka, A. (1995) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.152.5.7582298 · Cited by 45 · cited 2×
“The numerous and activated macrophages present in fibrotic lesions release exaggerated amounts of mediators capable of injuring lung parenchymal cells (e.g., superoxide anion and hydrogen peroxide) (41), recruiting neutrophils (TNF- , IL-1, and IL-8) (42, 43), or promoting the growth and/or collagen production of mese…”
Cited by
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092121 · Cited by 730
“5 C), which is consistent with related studies (Maeyama et al., 2001; Huaux et al., 2002; Sakamoto et al., 2002).”
ResultOku, H., Shimizu, T., Kawabata, T., Nagira, M., Hikita, I., Ueyama, A., Matsushima, S., Torii, M., & Arimura, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.046 · Cited by 436
IL-12p40: an inherently agonistic cytokine
Cooper, A. M., & Khader, S. A. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.11.002 · Cited by 344
Khader, S. A., Partida-Sanchez, S., Bell, G., Jelley-Gibbs, D. M., Swain, S., Pearl, J. E., Ghilardi, N., deSauvage, F. J., Lund, F. E., & Cooper, A. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052545 · Cited by 335
Novel IL-12 family members shed light on the orchestration of Th1 responses
Brombacher, F. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00067-x · Cited by 269
IL-1 and IL-23 Mediate Early IL-17A Production in Pulmonary Inflammation Leading to Late Fibrosis
Gasse, P., Riteau, N., Vacher, R., Michel, M.-L., Fautrel, A., di Padova, F., Fick, L., Charron, S., Lagente, V., Eberl, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023185 · Cited by 208
“IL-12p40 subunit, which associates with IL-23p19 subunit to form IL-23 cytokine, but neither IL-12p35 nor IL-12p70, was shown to play a key role in silica-induced pulmonary inflammation and fibrosis [44].”
BackgroundSelf-citationNew developments in the understanding of immunology in silicosis
Huaux, F. (2007) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e32802bf8a5 · Cited by 175
Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis
Cabrera, S., Maciel, M., Herrera, I., Nava, T., Vergara, F., Gaxiola, M., López-Otín, C., Selman, M., & Pardo, A. (2015) · Autophagy · doi:10.1080/15548627.2015.1034409 · Cited by 163
Chen, Y., Li, C., Weng, D., Song, L., Tang, W., Dai, W., Yu, Y., Liu, F., Zhao, M., Lu, C., et al. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.11.012 · Cited by 75
Metadata
- Authors
- Huaux, F., Arras, M., Tomasi, D., Barbarin, V., Delos, M., Coutelier, J.-P., Vink, A., Phan, S. H., Renauld, J.-C., & Lison, D.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-09-01
- Volume
- 169
- Issue
- 5
- Pages
- 2653-2661
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2132508910
- Cited by
- 87
- References
- 3
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.